
UTI Stock Forecast & Price Target
UTI Analyst Ratings
Bulls say
Universal Technical Institute Inc. demonstrated robust financial performance with a 19.3% year-over-year increase in total revenue, reaching $293.8 million, driven largely by significant growth in average full-time active enrollment, which rose by 8.1% to 15,207 students. The Concorde segment also contributed positively, with an 18.2% revenue growth to $77.8 million, reflecting strong demand for its programs and a strategic focus on marketing and admissions. Additionally, adjusted EBITDA saw a remarkable increase of 49.6% to $12.4 million, indicating effective cost management and operational efficiency alongside revenue growth.
Bears say
Universal Technical Institute Inc. has demonstrated a decline in key financial metrics, with adjusted EBITDA decreasing by 1.4% year-over-year and free cash flow down by 10.1%, signaling potential operational challenges ahead. Additionally, operating income fell by 4.0%, revealing shrinking profit margins, which could raise concerns among investors regarding the company's profitability. Despite a mixed initial guidance for FY/26 that included disappointing GAAP EPS projections, the market reaction was negative, resulting in an 18% drop in stock price, which reflects investor sentiment and ongoing uncertainties surrounding the company's financial stability.
This aggregate rating is based on analysts' research of Universal Technical Institute and is not a guaranteed prediction by Public.com or investment advice.
UTI Analyst Forecast & Price Prediction
Start investing in UTI
Order type
Buy in
Order amount
Est. shares
0 shares